Literature DB >> 16960919

Analysing multicentre competing risks data with a mixed proportional hazards model for the subdistribution.

Sandrine Katsahian1, Matthieu Resche-Rigon, Sylvie Chevret, Raphaël Porcher.   

Abstract

In the competing-risks setting, to test the effect of a covariate on the probability of one particular cause of failure, the Fine and Gray model for the subdistribution hazard can be used. However, sometimes, competing risks data cannot be considered as independent because of a clustered design, for instance in registry cohorts or multicentre clinical trials. Frailty models have been shown useful to analyse such clustered data in a classical survival setting, where only one risk acts on the population. Inclusion of random effects in the subdistribution hazard has not been assessed yet. In this work, we propose a frailty model for the subdistribution hazard. This allows first to assess the heterogeneity across clusters, then to incorporate such an effect when testing the effect of a covariate of interest. Based on simulation study, the effect of the presence of heterogeneity on testing for covariate effects was studied. Finally, the model was illustrated on a data set from a registry cohort of patients with acute myeloid leukaemia who underwent bone marrow transplantation. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 16960919     DOI: 10.1002/sim.2684

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  23 in total

1.  Competing risks regression for clustered data.

Authors:  Bingqing Zhou; Jason Fine; Aurelien Latouche; Myriam Labopin
Journal:  Biostatistics       Date:  2011-10-31       Impact factor: 5.899

2.  On cross-odds ratio for multivariate competing risks data.

Authors:  Thomas H Scheike; Yanqing Sun
Journal:  Biostatistics       Date:  2012-06-12       Impact factor: 5.899

3.  Hierarchical likelihood inference on clustered competing risks data.

Authors:  Nicholas J Christian; Il Do Ha; Jong-Hyeon Jeong
Journal:  Stat Med       Date:  2015-08-16       Impact factor: 2.373

4.  Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials.

Authors:  Antonio Palumbo; Anders Waage; Cyrille Hulin; Meral Beksac; Sonja Zweegman; Francesca Gay; Peter Gimsing; Xavier Leleu; Pierre Wijermans; Gülsan Sucak; Sara Pezzatti; Gunnar Juliusson; Brigitte Pégourié; Martijn Schaafsma; Monica Galli; Ingemar Turesson; Brigitte Kolb; Bronno van der Holt; Ileana Baldi; Jürgen Rolke; Giovannino Ciccone; Marc Wetterwald; Henk Lokhorst; Mario Boccadoro; Philippe Rodon; Pieter Sonneveld
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

5.  A competing risks model for correlated data based on the subdistribution hazard.

Authors:  Stephanie N Dixon; Gerarda A Darlington; Anthony F Desmond
Journal:  Lifetime Data Anal       Date:  2011-05-21       Impact factor: 1.588

6.  Estimating heritability for cause specific mortality based on twin studies.

Authors:  Thomas H Scheike; Klaus K Holst; Jacob B Hjelmborg
Journal:  Lifetime Data Anal       Date:  2013-02-02       Impact factor: 1.588

7.  A semiparametric random effects model for multivariate competing risks data.

Authors:  Thomas H Scheike; Yanqing Sun; Mei-Jie Zhang; Tina Kold Jensen
Journal:  Biometrika       Date:  2010-03       Impact factor: 2.445

8.  Methods for generating paired competing risks data.

Authors:  Ruta Brazauskas; Jennifer Le-Rademacher
Journal:  Comput Methods Programs Biomed       Date:  2016-07-25       Impact factor: 5.428

9.  Analysis of clustered competing risks data using subdistribution hazard models with multivariate frailties.

Authors:  Il Do Ha; Nicholas J Christian; Jong-Hyeon Jeong; Junwoo Park; Youngjo Lee
Journal:  Stat Methods Med Res       Date:  2014-03-11       Impact factor: 3.021

10.  Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials.

Authors:  Sara Bringhen; Maria Victoria Mateos; Sonja Zweegman; Alessandra Larocca; Antonietta Pia Falcone; Albert Oriol; Davide Rossi; Maide Cavalli; Pierre Wijermans; Roberto Ria; Massimo Offidani; Juan Jose Lahuerta; Anna Marina Liberati; Roberto Mina; Vincenzo Callea; Martijn Schaafsma; Chiara Cerrato; Roberto Marasca; Luca Franceschini; Andrea Evangelista; Ana-Isabel Teruel; Bronno van der Holt; Vittorio Montefusco; Giovannino Ciccone; Mario Boccadoro; Jesus San Miguel; Pieter Sonneveld; Antonio Palumbo
Journal:  Haematologica       Date:  2013-02-26       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.